Convatec Group PLC (LON:CTEC) Stock Has Consensus Price Target of GBX 305.44 According to Brokerages

Shares of Convatec Group PLC (LON:CTEC) have been given an average rating of “Moderate Buy” by the nine research firms that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is GBX 305.44.

A number of equities research analysts have commented on the stock. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a GBX 315 price target on shares of Convatec Group in a report on Wednesday, August 5th. Royal Bank Of Canada restated an “outperform” rating and issued a GBX 315 target price on shares of Convatec Group in a research note on Monday, August 3rd. Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 300 target price on shares of Convatec Group in a research report on Wednesday, August 5th. Peel Hunt reaffirmed an “add” rating and set a GBX 270 price target on shares of Convatec Group in a research note on Tuesday, August 4th. Finally, Berenberg Bank cut their price target on Convatec Group from GBX 340 to GBX 335 and set a “buy” rating on the stock in a report on Friday, September 11th.

Insider Activity at Convatec Group

In other news, insider Tobias Hestler acquired 50,000 shares of the firm’s stock in a transaction dated Thursday, August 6th. The stock was purchased at an average price of GBX 226 per share, for a total transaction of £113,000. 0.98% of the stock is currently owned by corporate insiders.

Convatec Group Price Performance

Shares of Convatec Group stock opened at GBX 217 on Monday. Convatec Group has a one year low of GBX 193 and a one year high of GBX 259.30. The company has a debt-to-equity ratio of 121.83, a current ratio of 1.93 and a quick ratio of 0.96. The stock’s 50-day moving average is GBX 223.88 and its 200 day moving average is GBX 218.04. The firm has a market cap of £4.21 billion, a price-to-earnings ratio of 35.00, a PEG ratio of 0.93 and a beta of 0.77.

About Convatec Group

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.